PRPF19 and hepatocellular carcinoma: circRNA-SORE hampers YBX1 nuclear interaction with the E3 ubiquitin ligase PRP19 and thus blocks PRP19-mediated YBX1 degradation, which mediates sorafenib resistance in HCC cells (66).